# Bristol-Myers Squibb Company (BMY) — Q1-2017 Earnings Results

**Report date:** 2017-04-27 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2017

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 3.53%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.84 | N/A | +13.33% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering innovative therapies.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's strong EPS performance indicates effective cost management and operational efficiency. The stock's positive reaction of 3.53% suggests investor confidence in the company's current trajectory, despite the lack of revenue data and future guidance. Investors may view the EPS beat as a sign of resilience in a competitive market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2017_